Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
392,193,323
-
Number of holders
-
784
-
Total 13F shares, excl. options
-
93,700,793
-
Shares change
-
-1,023,655
-
Total reported value, excl. options
-
$51,237,135,830
-
Value change
-
-$502,542,871
-
Put/Call ratio
-
84%
-
Number of buys
-
382
-
Number of sells
-
-311
-
Price
-
$546.86
Significant Holders of DEXCOM INC - Common Stock (DXCM) as of Q3 2021
877 filings reported holding DXCM - DEXCOM INC - Common Stock as of Q3 2021.
DEXCOM INC - Common Stock (DXCM) has 784 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 93,700,793 shares
of 392,193,323 outstanding shares and own 23.89% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (10,349,258 shares), BlackRock Inc. (7,628,230 shares), BAILLIE GIFFORD & CO (5,349,818 shares), FMR LLC (4,553,560 shares), STATE STREET CORP (3,913,243 shares), SANDS CAPITAL MANAGEMENT, LLC (3,324,368 shares), JPMORGAN CHASE & CO (2,993,285 shares), JANUS HENDERSON GROUP PLC (2,615,740 shares), Nuveen Asset Management, LLC (2,095,276 shares), and GEODE CAPITAL MANAGEMENT, LLC (1,794,553 shares).
This table shows the top 784 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.